Events / News

CUHK and HKSTP open a new ATP GMP Centre to fast-track the cell and gene therapy (CGT) manufacturing industry in Hong Kong and the GBA

State-of-the-art facility accelerates clinical trials to commercialisation with international PIC/S GMP-compliant manufacturing processes :

  • The new ATP GMP Centre will forge a world-class CGT manufacturing industry in Hong Kong and the Greater Bay Area.
  • CUHK collaboration boosts HKSTP’s mission to accelerate translation of scientific discoveries into life-saving biomedical innovations.
  • The centre features a highly skilled workforce, cluster development and excellent logistics infrastructure, speeding up CGT development.
Read More »

中大新中心研細胞基因治療產品 改造程序落戶本地 省時減成本

創科發展日漸成熟,癌症治療亦邁向科技化。中文大學成立「先進治療產品良好生產規範中心」下月正式啟用,是本港首個製造細胞及基因治療產品的科研機構,以基因改造細胞技術治療癌症、骨骼衰弱等,以往依賴海外完成的基因改造程序,有望改為本地研發,節省時間及成本;中心將與本地兩所醫院合作臨牀治療及研究。校長段崇智指,中心將積極推動生物醫學科技的研究,並歡迎其他院校加入。

Read More »

GMP Facility In Hong Kong To Accelerate Life-Saving Treatments

CUHK has entered into a new partnership with the Hong Kong Science and Technology Parks Corporation (HKSTP) to build a world-class Good Manufacturing Practice (GMP) facility in Hong Kong to accelerate the development of life-saving cancer therapies, regenerative medicine and related biomedical technologies.

Read More »

CUHK and HKSTP open a new ATP GMP Centre to fast-track the cell and gene therapy (CGT) manufacturing industry in Hong Kong and the GBA

State-of-the-art facility accelerates clinical trials to commercialisation with international PIC/S GMP-compliant manufacturing processes :

  • The new ATP GMP Centre will forge a world-class CGT manufacturing industry in Hong Kong and the Greater Bay Area.
  • CUHK collaboration boosts HKSTP’s mission to accelerate translation of scientific discoveries into life-saving biomedical innovations.
  • The centre features a highly skilled workforce, cluster development and excellent logistics infrastructure, speeding up CGT development.
Read More »

中大新中心研細胞基因治療產品 改造程序落戶本地 省時減成本

創科發展日漸成熟,癌症治療亦邁向科技化。中文大學成立「先進治療產品良好生產規範中心」下月正式啟用,是本港首個製造細胞及基因治療產品的科研機構,以基因改造細胞技術治療癌症、骨骼衰弱等,以往依賴海外完成的基因改造程序,有望改為本地研發,節省時間及成本;中心將與本地兩所醫院合作臨牀治療及研究。校長段崇智指,中心將積極推動生物醫學科技的研究,並歡迎其他院校加入。

Read More »

GMP Facility In Hong Kong To Accelerate Life-Saving Treatments

CUHK has entered into a new partnership with the Hong Kong Science and Technology Parks Corporation (HKSTP) to build a world-class Good Manufacturing Practice (GMP) facility in Hong Kong to accelerate the development of life-saving cancer therapies, regenerative medicine and related biomedical technologies.

Read More »